NM_005208.5:c.215+16C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005208.5(CRYBA1):c.215+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.031 in 1,374,546 control chromosomes in the GnomAD database, including 822 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.040 ( 170 hom., cov: 32)
Exomes 𝑓: 0.030 ( 652 hom. )
Consequence
CRYBA1
NM_005208.5 intron
NM_005208.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.184
Publications
4 publications found
Genes affected
CRYBA1 (HGNC:2394): (crystallin beta A1) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Beta-crystallins, the most heterogeneous, differ by the presence of the C-terminal extension (present in the basic group, none in the acidic group). Beta-crystallins form aggregates of different sizes and are able to self-associate to form dimers or to form heterodimers with other beta-crystallins. This gene, a beta acidic group member, encodes two proteins (crystallin, beta A3 and crystallin, beta A1) from a single mRNA, the latter protein is 17 aa shorter than crystallin, beta A3 and is generated by use of an alternate translation initiation site. Deletion of exons 3 and 4 causes the autosomal dominant disease 'zonular cataract with sutural opacities'. [provided by RefSeq, Jul 2008]
CRYBA1 Gene-Disease associations (from GenCC):
- cataract 10 multiple typesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- early-onset lamellar cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset nuclear cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset posterior polar cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset sutural cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 17-29250316-C-T is Benign according to our data. Variant chr17-29250316-C-T is described in ClinVar as [Benign]. Clinvar id is 259671.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0782 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0400 AC: 6075AN: 152032Hom.: 168 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6075
AN:
152032
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0262 AC: 6590AN: 251394 AF XY: 0.0254 show subpopulations
GnomAD2 exomes
AF:
AC:
6590
AN:
251394
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0298 AC: 36462AN: 1222396Hom.: 652 Cov.: 18 AF XY: 0.0293 AC XY: 18131AN XY: 619716 show subpopulations
GnomAD4 exome
AF:
AC:
36462
AN:
1222396
Hom.:
Cov.:
18
AF XY:
AC XY:
18131
AN XY:
619716
show subpopulations
African (AFR)
AF:
AC:
2405
AN:
29132
American (AMR)
AF:
AC:
752
AN:
44410
Ashkenazi Jewish (ASJ)
AF:
AC:
354
AN:
24618
East Asian (EAS)
AF:
AC:
8
AN:
38606
South Asian (SAS)
AF:
AC:
1777
AN:
81564
European-Finnish (FIN)
AF:
AC:
1055
AN:
53324
Middle Eastern (MID)
AF:
AC:
182
AN:
5176
European-Non Finnish (NFE)
AF:
AC:
28567
AN:
892988
Other (OTH)
AF:
AC:
1362
AN:
52578
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1576
3152
4727
6303
7879
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1046
2092
3138
4184
5230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0400 AC: 6090AN: 152150Hom.: 170 Cov.: 32 AF XY: 0.0385 AC XY: 2861AN XY: 74386 show subpopulations
GnomAD4 genome
AF:
AC:
6090
AN:
152150
Hom.:
Cov.:
32
AF XY:
AC XY:
2861
AN XY:
74386
show subpopulations
African (AFR)
AF:
AC:
3339
AN:
41474
American (AMR)
AF:
AC:
399
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
46
AN:
3470
East Asian (EAS)
AF:
AC:
2
AN:
5180
South Asian (SAS)
AF:
AC:
90
AN:
4814
European-Finnish (FIN)
AF:
AC:
197
AN:
10612
Middle Eastern (MID)
AF:
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1925
AN:
68004
Other (OTH)
AF:
AC:
63
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
295
590
885
1180
1475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
43
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Cataract 10 multiple types Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.